PFM Health Sciences as of June 30, 2023
Portfolio Holdings for PFM Health Sciences
PFM Health Sciences holds 80 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 5.4 | $140M | 299k | 468.98 | |
| Penumbra (PEN) | 4.8 | $124M | 360k | 344.06 | |
| Horizon Therapeutics Pub L SHS | 4.4 | $112M | 1.1M | 102.85 | |
| Cytokinetics Com New (CYTK) | 3.0 | $78M | 2.4M | 32.62 | |
| Centene Corporation (CNC) | 2.9 | $75M | 1.1M | 67.45 | |
| Humana (HUM) | 2.9 | $74M | 166k | 447.13 | |
| Merck & Co (MRK) | 2.7 | $69M | 596k | 115.39 | |
| Abbvie (ABBV) | 2.6 | $68M | 505k | 134.73 | |
| Edwards Lifesciences (EW) | 2.6 | $66M | 703k | 94.33 | |
| Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option (RSP) | 2.4 | $61M | 410k | 149.64 | |
| Cardinal Health (CAH) | 2.3 | $61M | 640k | 94.57 | |
| Intuitive Surgical Com New (ISRG) | 2.3 | $59M | 172k | 341.94 | |
| Biogen Idec (BIIB) | 2.2 | $57M | 198k | 284.85 | |
| UnitedHealth (UNH) | 2.2 | $56M | 116k | 480.64 | |
| Icon SHS (ICLR) | 2.1 | $53M | 214k | 250.20 | |
| Prothena Corp SHS (PRTA) | 2.1 | $53M | 775k | 68.28 | |
| Irhythm Technologies Call Option (IRTC) | 2.0 | $53M | 506k | 104.32 | |
| Axsome Therapeutics Call Option (AXSM) | 1.9 | $50M | 696k | 71.86 | |
| Seagen | 1.9 | $49M | 256k | 192.46 | |
| Hca Holdings (HCA) | 1.9 | $48M | 159k | 303.48 | |
| Dex (DXCM) | 1.9 | $48M | 375k | 128.51 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 1.8 | $47M | 679k | 69.03 | |
| Syndax Pharmaceuticals (SNDX) | 1.8 | $46M | 2.2M | 20.93 | |
| McKesson Corporation (MCK) | 1.8 | $45M | 106k | 427.31 | |
| Iqvia Holdings (IQV) | 1.8 | $45M | 201k | 224.77 | |
| Universal Hlth Svcs CL B (UHS) | 1.7 | $45M | 283k | 157.77 | |
| Molina Healthcare (MOH) | 1.7 | $43M | 144k | 301.24 | |
| Danaher Corporation (DHR) | 1.6 | $42M | 176k | 240.00 | |
| Tenet Healthcare Corp Com New (THC) | 1.6 | $42M | 511k | 81.38 | |
| Stryker Corporation (SYK) | 1.6 | $41M | 135k | 305.09 | |
| Argenx Se Sponsored Adr (ARGX) | 1.6 | $41M | 105k | 389.73 | |
| Becton, Dickinson and (BDX) | 1.6 | $41M | 154k | 264.01 | |
| Alkermes SHS (ALKS) | 1.4 | $36M | 1.2M | 31.30 | |
| Dynavax Technologies Corp Com New (DVAX) | 1.4 | $35M | 2.7M | 12.92 | |
| Anthem (ELV) | 1.3 | $33M | 75k | 444.29 | |
| Thermo Fisher Scientific (TMO) | 1.3 | $32M | 62k | 521.75 | |
| Acadia Healthcare (ACHC) | 1.2 | $30M | 381k | 79.64 | |
| BioMarin Pharmaceutical (BMRN) | 1.2 | $30M | 350k | 86.68 | |
| Karuna Therapeutics Ord | 1.2 | $30M | 138k | 216.85 | |
| Arcus Biosciences Incorporated (RCUS) | 1.1 | $29M | 1.4M | 20.31 | |
| Waters Corporation (WAT) | 1.0 | $25M | 95k | 266.54 | |
| Apellis Pharmaceuticals (APLS) | 1.0 | $25M | 275k | 91.10 | |
| Bluebird Bio (BLUE) | 0.9 | $24M | 7.3M | 3.29 | |
| Caribou Biosciences (CRBU) | 0.9 | $24M | 5.6M | 4.25 | |
| Ishares Tr China Lg-cap Etf Call Option (FXI) | 0.8 | $22M | 804k | 27.19 | |
| Sarepta Therapeutics (SRPT) | 0.7 | $19M | 166k | 114.52 | |
| Nevro Corp Note 2.750% 4/0 (Principal) | 0.6 | $16M | 18M | 0.93 | |
| Reata Pharmaceuticals Cl A | 0.6 | $15M | 145k | 101.96 | |
| Biomarin Pharmaceutical Note 0.599% 8/0 (Principal) | 0.6 | $15M | 15M | 0.98 | |
| Boston Scientific Corporation (BSX) | 0.6 | $15M | 268k | 54.09 | |
| Generation Bio (GBIO) | 0.6 | $14M | 2.6M | 5.50 | |
| Day One Biopharmaceuticals I (DAWN) | 0.5 | $14M | 1.1M | 11.94 | |
| Erasca (ERAS) | 0.5 | $13M | 4.8M | 2.76 | |
| Point Biopharma Global | 0.5 | $12M | 1.3M | 9.06 | |
| Abcam Ads | 0.5 | $12M | 476k | 24.47 | |
| Essa Pharma Com New (EPIX) | 0.4 | $11M | 4.2M | 2.70 | |
| Procept Biorobotics Corp (PRCT) | 0.4 | $10M | 296k | 35.35 | |
| Praxis Precision Medicines I | 0.4 | $10M | 8.9M | 1.15 | |
| Arcellx Common Stock (ACLX) | 0.3 | $8.1M | 256k | 31.62 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.3 | $7.7M | 8.4M | 0.93 | |
| Veeva Sys Cl A Com (VEEV) | 0.3 | $7.4M | 37k | 197.73 | |
| Immunovant (IMVT) | 0.3 | $7.4M | 389k | 18.97 | |
| Werewolf Therapeutics (HOWL) | 0.3 | $7.0M | 2.3M | 3.05 | |
| Miragen Therapeutics (VRDN) | 0.3 | $7.0M | 293k | 23.79 | |
| Zai Lab Adr (ZLAB) | 0.3 | $6.8M | 247k | 27.73 | |
| Iovance Biotherapeutics (IOVA) | 0.3 | $6.7M | 946k | 7.04 | |
| Rocket Pharmaceuticals (RCKT) | 0.2 | $4.7M | 239k | 19.87 | |
| Roivant Sciences SHS (ROIV) | 0.2 | $3.9M | 385k | 10.08 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $3.9M | 100k | 38.50 | |
| Editas Medicine (EDIT) | 0.1 | $3.6M | 441k | 8.23 | |
| Verve Therapeutics (VERV) | 0.1 | $3.5M | 186k | 18.75 | |
| Inhibrx | 0.1 | $3.3M | 128k | 25.96 | |
| Celcuity (CELC) | 0.1 | $2.8M | 258k | 10.98 | |
| Oscar Health Cl A (OSCR) | 0.1 | $2.7M | 336k | 8.06 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.1 | $1.5M | 175k | 8.28 | |
| Pmv Pharmaceuticals (PMVP) | 0.1 | $1.4M | 228k | 6.26 | |
| Io Biotech (IOBT) | 0.0 | $1.2M | 613k | 1.96 | |
| Keros Therapeutics (KROS) | 0.0 | $818k | 20k | 40.18 | |
| Uniqure Nv SHS (QURE) | 0.0 | $695k | 61k | 11.46 | |
| Sana Biotechnology (SANA) | 0.0 | $83k | 14k | 5.96 |
